MedPath

Evaluation of the specific bacteriophages to control of E.coli

Not Applicable
Conditions
rinary tract infection.
Urinary tract infection, site not specified
N39.0
Registration Number
IRCT20190624043991N14
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
20
Inclusion Criteria

Patients with recurrent urinary tract infections more than 3 positive cultures per year with E.coli
Age range 20-70 years
Consent to participate in the study

Exclusion Criteria

pregnant women
Patients with allergies

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rinary bacteria in patients with antibiotic-resistant urinary tract infections. Timepoint: Twice a week for three consecutive months. Method of measurement: Collect patients' urine samples and check the bacteria count.;Frequent urination in patients with antibiotic-resistant urinary tract infections. Timepoint: Twice a week for three consecutive months. Method of measurement: Collect patients' urine samples and check the bacteria count.;Dysuria in patients with antibiotic-resistant urinary tract infections. Timepoint: Twice a week for three consecutive months. Method of measurement: Collect patients' urine samples and check the bacteria count.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath